(c) 2024 PillSync.com

naproxen sodium naproxen sodium tablet

1 INDICATIONS AND USAGE Naproxen sodium tablets are indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis Polyarticular Juvenile Idiopathic Arthritis Naproxen sodium tablets are also indicated for: the relief of signs and symptoms of: tendonitis bursitis acute gout the management of: pain primary dysmenorrhea Naproxen sodium tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis Naproxen sodium tablets are also indicated for: the relief of signs and symptoms of: tendonitis bursitis acute gout the management of: pain primary dysmenorrhea

avkare, inc.


6 years ago OVAL BLUE IP 194 naproxen sodium naproxen sodium tablet

OVAL BLUE IP 194

6 years ago OVAL BLUE IP 194 naproxen sodium naproxen sodium tablet

IP 194 OVAL BLUE

16 HOW SUPPLIED/STORAGE AND HANDLING Naproxen Sodium Tablets, USP 275 mg, are supplied asblue, oval, biconvex, film coated tablets debossed “IP193” on obverse and plain on reverse. They are available as follows: Bottles of 100: NDC 42291-531-01 Naproxen Sodium Tablets, USP 550 mg, are supplied asblue, oval, biconvex, film coated tablets debossed “IP” bisect “194" on obverse and plain on reverse. They are available as follows: Bottles of 100: NDC 42291-532-01 Bottles of 500: NDC 42291-532-50 Store at 20Âș to 25ÂșC (68Âș to 77ÂșF); excursions permitted to 15Âș to 30ÂșC (59Âș to 86ÂșF) in well-closed containers.


More pills like OVAL IP 194












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site